Wound Levobupivacaine Continuous Infusion for Postoperative Analgesia in Living Kidney Donors: Case-Control Study

Continuous wound infusion with 5 mL/h−1 levobupivacaine, 1.5 mg/mL−1, resulted in a safe and effective analgesic protocol in LKDs both in the immediate postoperative period and in the first day after surgery, a result that was more effective than a morphine-tramadole regimen. No adverse effects were recorded, which confirmed the safety of the technique. It is probable that better results could be achieved with dedicated administration devices.